| Literature DB >> 28278143 |
Jami S Leichliter, Casey Copen, Patricia J Dittus.
Abstract
National-level data are limited regarding confidentiality-related issues and the use of sexually transmitted disease (STD) services for adolescents and young adults. Changes in the U.S. health care system have permitted dependent children to remain on a parent's health insurance plan until the child's 26th birthday and required coverage of certain preventive services, including some STD services, without cost sharing for most plans (1,2). Although these provisions likely facilitate access to the health care system, adolescents and young adults might not seek care or might delay seeking care for certain services because of concerns about confidentiality, including fears that their parents might find out (3,4). Therefore, it is important to examine STD services and confidentiality-related issues among persons aged 15-25 years in the United States. CDC analyzed data from the 2013-2015 National Survey of Family Growth and found that 12.7% of sexually experienced youths (adolescents aged 15-17 years and those young adults aged 18-25 years who were on a parent's insurance plan) would not seek sexual and reproductive health care because of concerns that their parents might find out. Particularly concerned were persons aged 15-17 years (22.6%). Females with confidentiality concerns regarding seeking sexual and reproductive health care reported a lower prevalence of receipt of chlamydia screening (17.1%) than did females who did not cite such concerns (38.7%). More adolescents aged 15-17 years who spent time alone with a health care provider (without a parent in the room) reported receipt of a sexual risk assessment (71.1%) and, among females, chlamydia testing (34.0%), than did those who did not spend time alone (36.6% and 14.9%, respectively). The results indicated that confidentiality-related issues were associated with less reported use of some STD services, especially for younger persons and females. Spending time alone with a provider (i.e., without a parent present) during a health care visit has been associated previously with higher reported delivery of sexual health services (5) and has been suggested by the American Academy of Pediatrics and Society for Adolescent Health and Medicine (6). Public health efforts related to confidentiality of STD services might be helpful to increase the use of recommended services among some youths.Entities:
Mesh:
Year: 2017 PMID: 28278143 PMCID: PMC5687195 DOI: 10.15585/mmwr.mm6609a1
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Percentage of sexually experienced* females and males aged 15–25 years who said they would not seek sexual or reproductive health care because their parents might find out,† by demographic and behavioral characteristics — National Survey of Family Growth, United States, 2013–2015
| Characteristic | Estimated pop. | % (95% CI) | p-value |
|---|---|---|---|
|
|
|
| — |
|
| |||
| Female | 8,058,000 | 13.5 (10.1–16.9) | 0.510 |
| Male | 9,019,000 | 12.0 (8.5–15.6) | |
|
| |||
| 15–17 | 4,915,000 | 22.6 (17.6–27.6) | <0.001 |
| 18–19 | 3,013,000 | 14.1 (6.5–21.7) | |
| 20–22 | 5,361,000 | 8.2 (4.2–12.2) | |
| 23–25 | 3,789,000 | 5.4 (2.4–8.3) | |
|
| |||
| Hispanic | 2,985,000 | 14.7 (8.3–21.1) | 0.161 |
| White, non-Hispanic | 10,746,000 | 12.1 (8.8–15.4) | |
| Black, non-Hispanic | 2,115,000 | 9.9 (4.9–14.9) | |
| Other or multiple race, non-Hispanic | 1,232,000 | 18.5 (8.0–28.9) | |
|
| |||
| At elevated STD risk | 1,981,000 | 17.1 (9.6–24.7) | 0.225 |
| Not at elevated STD risk | 14,995,000 | 12.2 (9.4–15.0) | |
Abbreviations: CI = confidence interval; STD = sexually transmitted disease.
* Sexually experienced was defined as those who have ever had vaginal intercourse, oral sex, or anal sex, with an opposite-sex or same-sex partner in their lifetime.
† For respondents aged 18–25 years, this question was only asked if they were on a parent’s private health insurance plan.
§ Included male-to-male sex, females who had a male sex partner who had sex with other males, five or more sexual partners, sex in exchange for money or drugs, a sex partner who injected illegal drugs, or a human immunodeficiency virus–positive partner in the past 12 months.
Percentage of sexually experienced* females and males aged 15–25 years who had received a selected STD-related service in the past 12 months, by confidentiality-related, sexual risk, and demographic characteristics — National Survey of Family Growth, United States, 2013–2015
| Characteristic | Total | Females | Males | |||||
|---|---|---|---|---|---|---|---|---|
| Sexual risk assessment % (95% CI)† | p-value | STD treatment % (95% CI)§ | p-value | Chlamydia test % (95% CI) | p-value | STD test % (95% CI)¶ | p-value | |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
|
| ||||||||
| Yes | 48.0 (39.6–56.4) | 0.666 | 5.9 (1.3–10.5) | 0.957 | 17.1 (6.6–27.7) | 0.002 | 13.0 (4.4–21.6) | 0.426 |
| No | 49.9 (46.1–53.7) | 5.8 (3.8–7.7) | 38.7 (34.0–43.4) | 16.7 (13.0–20.4) | ||||
|
| ||||||||
| Yes | 71.1 (62.8–79.3) | <0.001 | 6.6 (1.1–12.0) | 0.072 | 34.0 (20.9–47.1) | 0.021 | 13.6 (5.5–21.7) | 0.424 |
| No | 36.6 (30.4–42.9) | 1.4 (0.3–2.5) | 14.9 (7.3–22.5) | 9.5 (4.1–15.0) | ||||
|
| ||||||||
| Private insurance, parent’s plan | 49.3 (45.3–53.3) | <0.001 | 5.7 (3.8–7.6) | 0.013 | 36.3 (30.9–41.6) | 0.242 | 16.2 (12.1–20.3) | 0.034 |
| Private insurance, other | 44.4 (37.1–51.6) | 4.1 (2.2–6.1) | 40.2 (29.0–51.4) | 19.4 (11.5–27.3) | ||||
| Public insurance | 51.9 (46.4–57.5) | 7.2 (4.9–9.6) | 43.4 (37.8–49.0) | 24.9 (18.9–30.8) | ||||
| No insurance | 38.2 (33.6–42.8) | 9.7 (6.2–13.2) | 35.4 (28.0–42.7) | 24.7 (18.4–31.0) | ||||
|
| ||||||||
|
| ||||||||
| Yes | — | — | 10.9 (9.1–12.8) | <0.001 | 51.1 (47.1–55.0) | <0.001 | 42.9 (37.2–48.5) | <0.001 |
| No | — | — | 2.4 (1.2–3.6) | 18.8 (14.2–23.3) | 8.7 (6.3–11.2) | |||
|
| ||||||||
| At elevated STD risk | 60.6 (54.3–66.9) | 0.001 | 19.6 (13.4–25.8) | <0.001 | 61.1 (50.8–71.3) | <0.001 | 44.4 (32.3–56.6) | 0.001 |
| Not at elevated STD risk | 45.8 (42.6–49.0) | 4.9 (3.8–5.9) | 36.9 (33.9–39.7) | 15.9 (13.4–18.3) | ||||
|
| ||||||||
|
| ||||||||
| 15–17 | 50.9 (45.5–56.4) | 0.196 | 3.5 (1.1–5.9) | 0.045 | 23.5 (16.5–30.4) | <0.001 | 10.7 (6.6–14.9) | 0.002 |
| 18–19 | 51.3 (44.4–58.3) | 7.6 (4.5–10.7) | 31.4 (24.0–38.9) | 15.4 (9.9–21.0) | ||||
| 20–22 | 47.0 (42.5–51.5) | 5.6 (3.9–7.4) | 46.1 (40.7–51.6) | 20.7 (16.2–25.2) | ||||
| 23–25 | 44.9 (40.8–48.9) | 8.0 (5.6–10.3) | 40.6 (35.3–45.9) | 27.4 (20.8–34.1) | ||||
|
| ||||||||
| Hispanic | 49.1 (43.7–54.5) | 0.001 | 5.6 (3.7–7.6) | <0.001 | 35.8 (28.8–42.7) | <0.001 | 23.9 (18.5–29.4) | <0.001 |
| White, non-Hispanic | 44.0 (40.0–48.0) | 4.9 (3.7–6.2) | 35.4 (31.3–39.5) | 14.3 (11.1–17.5) | ||||
| Black, non-Hispanic | 59.9 (54.9–64.8) | 12.6 (9.4–15.9) | 56.1 (49.5–62.7) | 38.4 (30.3–46.4) | ||||
| Other or multiple race, non-Hispanic | 43.6 (36.1–51.1) | 7.2 (2.4–12.1) | 35.1 (24.9–45.4) | 15.8 (5.9–25.7) | ||||
Abbreviations: CI = confidence interval; STD = sexually transmitted disease.
* Sexually experienced was defined as those who have ever had vaginal intercourse, oral sex, or anal sex, with an opposite-sex or same-sex partner in their lifetime.
† Based on at least one “yes” response to four questions asking whether a doctor or other medical care provider asked about the sexual orientation or the sex of their sexual partners, number of sexual partners, use of condoms, and the types of sex they have (vaginal, oral, or anal).
§ “In the past 12 months, have you been treated or received medication from a doctor or other medical care provider for a sexually transmitted disease like gonorrhea, chlamydia, herpes, or syphilis?”
¶ “In the past 12 months, have you been tested by a doctor or other medical care provider for a sexually transmitted disease like gonorrhea, chlamydia, herpes, or syphilis?”
** For respondents aged 18–25 years, this question was only asked if they were on a parent’s private health insurance plan.
†† Included male-to-male sex, females who had a male sex partner who had sex with other males, five or more sexual partners, sex in exchange for money or drugs, a sex partner who injects illegal drugs, or a human immunodeficiency virus (HIV)–positive partner in the past 12 months.